Infirst takes first step towards US Flarin launch
Premium
17 November 2021
Infirst has taken the first step towards launching Flarin – its lipid-formulated ibuprofen medicine – in the US.
You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
17 November 2021
Infirst has taken the first step towards launching Flarin – its lipid-formulated ibuprofen medicine – in the US.
6 April 2021
Royal DSM is investing USD100 million in a new personalised nutrition company called Hologram Sciences and Flarin has completed a second fundraising round.